Real Time with Ruby is an even aimed at strengthening the mind, working the body, and encouraging the spirit. Ruby Gettinger's journey to a better life is an inspiration to others accomplishing the ...
GSK plc announced statistically significant and clinically meaningful overall survival (OS) results from Part 1 and progression-free survival (PFS) results from Part ...
GSK plc (NYSE:GSK) released headline results from a planned analysis of Part 1 of the RUBY phase 3 trial of Jemperli (dostarlimab) plus standard-of-care chemotherapy (carboplatin and paclitaxel), ...
Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Wes Reisz discusses an experiment to deliver ...
GSK has said that a regimen of PD-1 inhibitor Jemperli with PARP inhibitor Zejula has shown efficacy in the second stage of the RUBY trial, which could open up wider use in endometrial cancer. RUBY ...
The European Network for Gynaecological Oncological Trial (ENGOT) groups, the Nordic Society of Gynaecological Oncology – Clinical Trial Unit (NSGO-CTU) and the GOG Foundation, Inc. (GOG-F) are proud ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback